Etidronate Disodium Tablets

This product is a bone metabolism regulator. It has a strong affinity for calcium phosphate in the body, can inhibit abnormal calcification and excessive bone absorption in the human body, relieve bone pain, reduce the concentration of serum alkaline phosphatase and urinary hydroxyproline; at low doses, it can directly inhibit osteoclast formation and prevent bone absorption, reduce bone turnover rate, increase bone density, etc. to achieve bone calcium regulation.

The main ingredient of this product is: etidronate disodium. Its chemical name is: (1-hydroxyethylidene) diphosphonic acid disodium salt.

This product is a white tablet.

Used for postmenopausal osteoporosis and aging-related osteoporosis.

Oral administration: 0.2 g at a time, twice a day, between meals.

Symptoms include abdominal discomfort, diarrhea, soft stools, vomiting, stomatitis, burning sensation in the throat, headache, itchy skin, and rash.

Contraindicated for patients with high blood pressure

Precautions for children: Long-term use may affect bone metabolism and should be used with caution. Precautions for pregnancy and lactation: Animal experiments can cause bone deformities, and the drug can be excreted through breast milk, so it is forbidden for pregnant and lactating women. Precautions for the elderly: Reduce the dosage appropriately.

Not yet clear

Keep away from light, sealed and stored in a dry place.

0.2 g

24 months

Beijing Juneng Pharmaceutical Co., Ltd.

• Founded in:

  1997-03-17

• Address:

  No. 3, Yongchang North Road, Beijing Economic and Technological Development Zone, Beijing

• Tax NO.:

  911103026337907787

• Registered Funds:

  14 million yuan

• Email:

  Log in to view